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With the trend towards miniaturization, microscale sample preparation techniques 
are attracting more attention in analytical chemistry. This work focused on one 
microscale sample preparation approach – liquid-liquid-liquid microextraction 
(LLLME), which is quick, inexpensive and uses simple equipment found in most 
analytical laboratories. The development and applications of this microextraction 
procedure including investigation of the parameters that influence extraction, and the 
evaluation of the applicability of the method to drug analysis are described. 
Firstly, the present work demonstrated the potential of LLLME for the enrichment 
of basic drugs present in water samples with analysis by capillary electrophoresis 
(CE). Parameters that influenced the extraction efficiency were investigated. It proved 
to be an effective method for the analysis of amino alcohols from aqueous samples.  
   Secondly, LLLME was combined with liquid chromatography-mass 
spectrometry (LC-MS) for the analysis of drugs in biological matrices. This is the 
first report on the combination of LLLME and LC-MS. LLLME resulted in high 
preconcentration and efficient sample clean-up. LLLME-LC-MS was demonstrated to 
be a promising combination for drugs analysis in biological matrices. 
    Thirdly, a novel two-step liquid-liquid-liquid microextraction technique was 
developed and applied to analyze two nonsteroidal anti-inflammatory drugs in 
wastewater sample with reversed-phase high performance liquid chromatography. 
Key parameters like the concentration of donor and acceptor solutions and extraction 
times were investigated. Sensitivity enhancement of >15000-fold could be achieved.  





















  Drug analysis is growing in importance owing to the need to understand 
therapeutic and toxic effects of drugs and the continuing development of more 
selective and effective drugs [1-3]. Interest in drug analysis is being focused on 
improving methodologies, and how rapid, accurately and sensitively the chemicals 
can be detected. This field is highly dependent on the development of new analytical 
instruments or techniques.  
In past decades, most efforts in the analytical field have been focused on the 
development of instruments to speed up the analysis and increase method sensitivity. 
Chromatographic methods have been the most effective techniques to separate and 
identify chemical compounds. The development of gas chromatography (GC), high 
performance liquid chromatography (HPLC) has contributed significantly to the 
discovery and monitoring drugs in the environmental and biological samples [4-15]. 
More recently, capillary electrophoresis (CE) has also been widely applied to drug 
analysis as its advantages of small sample injection volumes and high resolution 
[16-22]. Nuclear magnetic resonance (NMR) spectrometry and mass spectrometry 
(MS) are highly valued and widely used now because of their intrinsic capabilities of 
providing analytical results with high specificities [23-33]. Modern automated 
chromatographic, spectrometric and mass spectroscopic instruments, as well as 
hyphenated methods allow analysis to be carried out more rapidly and with greater 
sensitivity and precision [34]. 
Although high capability instruments have been developed, most analytical 
instruments cannot handle the sample matrix directly. Therefore, sample preparation 
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is very important to achieve a practical and reliable method for the analysis of 
complex matrices, such as biological samples. Experience has shown that sample 
preparation is often perceived as the bottleneck in an analytical method because it is 
usually the most time-consuming and tedious part of the whole procedure. The 
potential for error is also highest during this step due to multi-transfer and operational 
procedures. The main challenges encountered in any analysis, particularly drug 
analysis, are the minimization or elimination of matrix components that interfere with 
the target compounds, the achievement of low detection limits and the identification 
of unknown drug compounds. Since conventional detection methods coupled with 
separation techniques do not provide the sensitivity required for low amounts of drugs, 
enrichment and matrix removal procedures are desirable. The development of sample 
preparation currently is a significant challenge and sample preparation is becoming a 
very exciting area of research. 
 
 
2 Traditional sample preparation techniques 
 
In many analytical procedures, sample preparation is critical for obtaining 
accurate and reliable results. The goals of sample preparation are to isolate analytes 
from the complex sample matrix that cannot be handled by the analytical instrument 
directly and to bring the analytes to a suitable concentration level for analysis. Also, 
amenability to automation is increasingly a desirable attribute of sample preparation 
[35].  
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In the analysis of drugs, liquid-liquid extraction and solid-phase extraction are the 
most commonly used techniques for preconcentration and cleanup of samples prior to 
chromatographic analysis. 
 
2.1 Liquid-liquid extraction  
Liquid-liquid extraction (LLE) is widely used and generally accepted for sample 
pretreatment of drugs [36-41]. In LLE, hydrophobic sample constituents are extracted 
from aqueous samples with a water-immisible organic phase. The basic principle 
underlying this technique is “like dissolves like”. As organic compounds, drugs 
partition preferably into organic solvents. Extraction is determined by two main 
factors: solubility and equilibrium. For an analyte i, the extraction process may be 
illustrated with the equation: 
isample↔iorganic 
At equilibrium, the partition coefficient ki (for the analyte i) in the two-phase system 
is  
                 ki = Cio /Cis                                 (1-1) 
where Cio, Cis is the equilibrium concentration of i in the extraction solvent and in the 
sample phase, respectively. 
Solvent selection is critical in LLE. Important parameters that have to be 
considered when selecting an appropriate solvent for the intended extraction system 
include density, volatility, polarity, selectivity, and solubility of the drugs. The main 
criteria for selection are that the solvent is immiscible with water, has optimum 
polarity to match that of the analyte, is volatile if it is to be evaporated to dryness, or 
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is compatible with the next stage of analysis if it is to be injected directly into a 
chromatograph and is preferably of low toxicity and environmentally-friendly. 
Uncharged solutes are more easily extracted into nonpolar organic solvents, and polar 
solutes are extracted into polar solvents. The major problem for extracting polar 
solutes is the miscibility of polar solvents with water, which is the main matrix for 
many samples. The chemical form of an analyte has a fundamental effect on the 
efficiency of an extraction. Important parameters of commonly used solvents are 
listed in Table 1-1. 
For successful LLE, the analyte should be extracted quantitatively from the sample 
and into the organic solvent; the extraction efficiency E= [extracted amounts of 
i/organic amount of i in the sample]×100% should be close to 100%. It is closely 
related to both the partition coefficient (ki) and to the volume of organic solvent used 
for the extraction (Vo).  
E=1/[(Vs/kiVo)+1]                      (1-2) 
Vs is the volume of the sample. High extraction efficiencies may be obtained in 
general by utilizing a large volume of organic solvent relative to the volume of the 
sample. The extract (organic phase) is normally evaporated to dryness and the residue 
is reconstituted in a small volume of a suitable liquid phase compatible with the 






Table 1-1. Important parameters for commonly used solvents in LLE. 








n-Pentane 210 36 0.626 0.0 
n-Hexane 210 69 0.660 0.1 
n-Heptane 210 98 0.684 0.2 
Cyclohexane 210 81 0.721 0.2 
Carbon tetrachloride 265 77 1.594 1.6 
Benzene 280 80 0.877 2.7 
Toluene 285 111 0.867 2.4 
Diisopropyl ether 220 68 0.726 2.4 
Diethyl ether 220 35 0.713 2.8 
Dichloromethane _ 40 1.327 3.1 
Tetrahydrofuran 220 66 0.881 4.0 
Chloroform 245 61 1.483 4.1 
Acetone 330 56 0.790 5.1 
Ethyl acetate 260 77 0.902 4.4 
Cyclohexanol _ 161 0.962 4.7 
n-Butanol 215 118 0.810 4.1 
Ethanol 210 79 0.789 4.3 
Dioxane 215 101 1.033 4.8 
Methanol 210 65 0.792 5.1 
Pyridine 330 115 0.980 5.3 
Acetonitrile 190 82 0.786 5.8 
Acetic acid 260 118 1.049 6.0 
Formamide 270 211 1.133 9.6 
Water 191 100 1.000 10.2 
 
From a practical point of view, the evaporation step for LLE is cumbersome and 
may cause losses of the analyte. But LLE provides a degree of sample clean-up. Both 
inorganic salts and biological macromolecules are insoluble in the organic solvents 
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used for LLE, thus they remain in the aqueous sample phase and so are effectively 
removed by LLE. LLE suffers from several limitations, such as large volume of 
solvent use, labor intensity, tendency for emulsion formation, and poor potential for 
automation. It is still a frequently used method for sample preparation. Its advantages 
are general acceptance for standard methods, simplicity of method development, 
generally good reproducibility and high sample capacity.  
 
2.2 Solid-phase Extraction  
Solid-phase extraction (SPE) has now been widely adopted for the analysis of 
drugs of abuse in biological matrices [43-59]. It involves passing a liquid sample 
through small, disposable cartridge systems containing solid absorbents as the media 
for retaining the compounds of interest, followed by selective elution in a small 
volume of clean extract. A normal SPE sequence might involve the following four 
steps:  
(i) Condition the sorbent with suitable solvents. The purpose is to solvate the 
functional groups of the sorbent and to drive out the air in the column. Typical 
conditioning solvent is methanol followed by water or buffer. Be careful not to allow 
the packing to go dry. 
(ii) Apply the sample. For drug analysis, small amount of sample (usually 1 to 2 ml) 
may be applied to the column. The retention mechanism that holds the analyte to the 
column includes van der Waals (also called nonpolar, hydrophobic, partitioning, or 
reversed-phase) interaction, hydrogen bonding, dipole-dipole forces, size exclusion 
and cation and anion exchange. During this retention step, the analyte is concentrated 
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on the sorbent.  
(iii) Rinse the column to remove some interferents and to retain the analyte.  
(iv)Elute the analyte in a small volume of solvent. An appropriate solvent is 
specifically chosen to disrupt the analyte-sorbent interaction. The solvents selected 
are just strong enough to elute the analyte but leaving more strongly bound 
interferents on the column.  
The sorbents used for SPE are similar to those used in HPLC, including normal 
phase, reversed phase, and ion exchange materials. Table 1-2 lists the common 
sorbents used in SPE [42]. Three main modes of separation are: normal phase, using a 
stationary phase that is more polar than the solvent or sample matrix; reverse phase, 
with nonpolar bonded sorbents, commonly used when aqueous samples are involved; 
and ion-exchange, using charged bonded sorbents, where the charged analyte 
exchange for another charged analyte that already is sorbed to the ion-exchange resin. 
The SPE approach offers the following advantages over LLE procedures: 1) less 
organic solvent usage; 2) No foaming problems; 3) Shorter sample-preparation time; 
and 4) Ease of incorporation into an automatic operation process. Additionally, SPE 
provides higher enrichment factors and it is inexpensive. However, it does have some 
limitations such as low recovery, plugging of the cartridge or blocking of the pores in 
the sorbent by solid or oily components and it is limited to semivolatile or nonvolatile 





Table 1-2. Column selection in SPE. 
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SCX Benzenesulphonic acid 
PRS Propylsulphonic acid 
CBA Carboxylic acid 








High ionic strength 
buffer 





SAX Bebznesulphonic acid 
PSA Primary/secondary amine 
NH2 Aminopropyl 
DEA Diethylaminopropyl 












High ionic strength 
buffers 
Phosphate and acetate 
 
The disadvantage of LLE and SPE is the considerable expense of time and manual 
operations. Sample throughput is low. LLE and SPE may also result in analyte losses, 
contamination, and generally poorer precision. Therefore, recent work on sample 
preparation has focused on the development of simpler (preferably one-step), 




3 Microextraction  
 
Modern analytical techniques require accompanying sample preparation methods 
that not only have good analytical performance characteristics, including efficiency, 
selectivity and be applicable to various compounds and matrices, but are also easy to 
use, inexpensive and compatible with a wide range of analytical instruments. 
In this respect, miniaturization has became an important trend in the development 
of sample preparation techniques, for it offers solutions that are simpler, faster, and 
more environmentally and economically attractive than conventional ones. The 
development of micro-scale extraction techniques has been driven by these 
requirements. 
Microextraction is defined as an extraction technique where the volume of the 
extracting phase is very small in relation to the volume of the sample, and extraction 
of analytes is not exhaustive. The basic principle is to employ microliter levels of 
extracting phase selectively to extract or enrich target compounds from the bulk 
sample matrix.  Partitioning is controlled by physicochemical properties of the 
analyte, not dependent on analyte concentration. Thus quantification of sample 
concentration may be determined from absolute amount extracted. Based on the 
extracting phase, microextraction methods currently can be classified into 
sorbent-based microextraction (60-75) and solvent-based microextraction (35, 































    
 
 
Figure 1-1 Classification of microextraction techniques. (For explanation of 














3.1 Sorbent-based microextraction 
Microextraction of drugs has, to date, found its greatest application with the 
technique of solid phase microextraction (SPME) and in particular fibre SPME. 
SPME is an effective adsorption and desorption technique, which eliminates the need 
for solvents or complicated apparatus. It has the potential to significantly simplify 
sample preparation, and integrate it with sample analysis. Introduced in 1990 by 
Arthur and Pawliszyn [60], it has been shown to be useful for many drug analysis 
applications, coupled to analysis by standard chromatography instruments (GC, 
GC-MS, HPLC, LC-MS, CE) [61-75].  
The principle of SPME is based on the partitioning of analytes between sample 
matrixes and a small amount of the polymer-coated stationary phase (usually less than 
1 µl) on a silica fiber. It takes advantages of equilibrium extraction and selective 
sorption from the matrix onto the coating. Firstly, the polymer-coated, fused silica 
fibre is exposed to the sample and analytes with a high affinity for the sorbent are 
selectively extracted.  If the extraction time is long enough, an equilibrium is 
established between the sample matrix and the extraction phase. After that the fibre 
bearing the analytes is transferred to the analytical instrument where desorption, 
separation and quantification of extracted analytes take place. The fibre is contained 
in a syringe-like device to facilitate handling.  An important feature of SPME is the 
intergration of extraction and injection in the same fiber. No intermediate clean-up 
step is normally implemented. The SPME device has been available commercially for 
some years. 
SPME is not an exhaustive extraction technique. The amount of an analyte 
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extracted by the coating at equilibrium is determined by the magnitude of the 
partition coefficient (distribution ratio) of the analyte between the sample matrix and 
the coating material. The extraction phase can be either high molecular weight 
polymeric liquid, similar in nature to stationary phases in chromatography, or it can 
be a solid sorbent, typically of a high porosity to increase the surface area available 
for adsorption. The physical and chemical properties of the coating are crucial for the 
partition process. The main commercial available coatings are polydimethylsiloxane 
(PDMS) of different film thickness, polyacrylate (PA), and mixed phases coatings, 
polydimethylsiloxane-divibylbenzene (PDMS-DVB), polyethylene 
glycol-polydivinylbenzene (Carbowax-DVB), and polyethylene glycol-template 
polydivinylbenzene resin (Carbowax-TR). Selection of the coating is mainly based on 
the principle “like dissolve like”.  PDMS is a nonpolar phase which is used to 
extract non-polar compounds. It is the most popular coating currently used. PDMS is 
very rugged liquid coating which is able to withstand high injector temperatures, up 
to about 300oC.  PA is more polar and can be used for the extraction of polar 
compounds, such as phenols. It is a low density solid polymer at room temperature. 
Mixed phase are mainly used for the extraction of volatile compounds. They have 
complementary properties compared to PDMS and PA. 
3.2 Solvent-based microextraction 
LLE and SPE use a large amount of solvent, which influences trace analysis and 
causes environmental pollution and health concerns. Initial efforts to address the 
problems of large solvent consumption and poor automation included the 
development of flow injection extraction (FIE). FIE was first described in 1978 by 
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Karlberg and Thelander [77] and by Bergamin et al [78]. In conventional FIE 
procedures, an aqueous sample is injected into an aqueous carrier stream. Organic 
segments are then continuously inserted into the streams. After the segmented stream 
passes through a coil in which extraction occurs, the organic phase is separated from 
the aqueous phase and led through a flow cell for measurement. Both segmentation 
and phase separation are critical aspects of the FIE technique with respect to 
reliability and precision. In most FIE methods in use, no further chemistry is carried 
out after the extraction step. Extraction is quantitative and analyte determination is 
performed by measuring optical absorption in the organic phase. Compared with 
traditional LLE, FIE offers the advantages of high speed, low cost and reduced 
solvent/sample consumption. While the method is attractive, solvent consumption is 
still on the order of several hundred microliters per analysis.  
A newly developed protocol, which overcomes the problems of solvent 
evaporation (LLE, SPE) and fiber degradation (SPME), is solvent microextraction 
(SME), now more commonly termed liquid-phase microextraction (LPME). It is 
based on the traditional LLE technique but involves only a few microliters of organic 
solvent as extractant. Single drop extraction (SDE) and hollow fiber protected 
microextraction are two modes of SME. 
3.2.1 Single drop extraction (SDE) 
Single drop extraction features the use of a discrete drop of immiscible solvent 
suspended in true sample matrix for the enrichment of analytes. Recent publications 
in this field have demonstrated applications for drug analysis.  
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3.2.1.1 Liquid-phase microextraction or solvent microextraction 
In early work Liu and Dasgupta reported extraction of SDS ion pairs into a 
stationary organic drop (~1.3 µl) suspended inside a flowing aqueous drop [79]. The 
importance of convective transport of analyte is described. Vibration in the aqueous 
drop and elimination of organic microdrop evaporation are discussed. Analysis is by 
optical absorbance and the authors propose drop-in-drop extraction for further 
enhancement of extraction efficiency. 
Jeannot and Cantwell described a relatively simple SME technique [80, 81]. A 
single microdrop of toluene was suspended on the tip of either a PTFE rod or a gas 
chromatography (GC) microsyringe needle which was immersed in the stirred 
aqueous sample solution. After extraction the drop is injected directly into a gas 
chromatograph for analysis. They provide a good treatment of the kinetics and 
diffusion of the process. It was found that mass transfer is proportional to diffusion 
coefficients. The extraction speed is strongly affected by observed rate constant k (s-1), 
which is related to the overall mass transfer coefficient β0. 
k = (Ai/Vo) β0 [к (Vo/Vaq) +1]                       (1-3) 
Where Vo and Vaq are the volumes of the organic and aqueous phases, respectively; Ai 
is the interfacial area, β0 is the overall mass-transfer coefficient with respect to the 
organic phase and к is the distribution coefficient. The evidence provides support for 
the film theory of convective-diffusive mass transfer rather than penetration theory.  
The film theory was first proposed by Nernst [82] and further developed by 
Lewis and Whitman [83, 84], assumes no movement of the solution immediately 
adjacent to the interface (e.g., one molecule thick) and a gradually increasing 
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vigorousness of convection  of the solution at locations farther away from the 
interface. This condition, which is difficult to treat mathematically, is approximated in 
film theory by postulating that uniform, instantaneous, and complete convective 
mixing exists in the bulk solution to some distance δ cm away from the liquid-liquid 
interface. The liquid layer of thickness δ, called the Nernst diffusion film, is 
postulated to be completely stagnant and nonconvected, so that a sample molecule 
crosses it by pure diffusion only. At steady state, the aqueous phase mass transfer 
coefficient is given by  
βaq= Daq/δaq                               (1-4) 
where Daq is the diffusion coefficient in the aqueous phase. At faster stirring rates, βaq 
increases because δaq decreases. 
Jeannot and Cantwell later applied the method to study progesterone binding to 
bovine serum albumin (BSA) with GC analysis [84]. Progesterone was extracted into 
a 1-µl drop of n-octane suspended on a microsyringe needle tip. A very low phase 
ratio was used (2×10-6 mL of organic/mL of water). 
3.2.1.2 Static LPME and dynamic LPME 
He and Lee reported on static and dynamic liquid-phase microextraction (LPME) 
[85]. In static LPME, the 1-µl organic microdrop located on the needle tip of 
microsyringe was exposed directly to the stirred aqueous sample solution, while mass 
transfer of analytes from aqueous sample to organic drop occurred through the effect 
of diffusion. In the dynamic extraction, 1-µl of toluene is first drawn into the needle 
and the needle tip was placed into the aqueous sample. Extraction was performed 
using the syringe by drawing and dispensing 3-µl of sample 20 times. Extraction 
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occurred both into the solvent plug located near the syringe plunger and into the 
solvent film that formed on the walls of the syringe barrel (Figure 1-2). Extraction 
into the film was more efficient than extraction into the plug. This extraction scheme 
resulted in a 27× enrichment, a 3min extraction, and 13% relative standard deviation 
(RSD) while static extraction gave a 12× enrichment, 15 min extraction time and 10% 
RSD. After extraction, the extract can be directly injected into a gas chromatograph 
(GC) for analysis. They are shown to be fast, economical, and simple one-step 
microextraction techniques. This work was extended for the analysis of ten 
chlorobenzenes with GC analysis [86]. The movement pattern of the plunger was the 
key operation in dynamic LPME. Parameters, such as plunger speed, dwell time, 
extraction solvent, sampling volume, and salt addition on the extraction performance 
were investigated. Salt in the sample was found to decrease extraction, possibly by 
having an adverse effect on the extraction film. 
Compared with static LPME, dynamic LPME provides higher enrichment within 
a much shorter time, but has lower reproducibility, which can conceivably be 
improved by automation [86]. Dynamic LPME shares the advantage with FIE in 
terms of high extraction speed and low operation cost. However, in FIE, the phase 
ratio, which governs the ultimately enrichment factor, can only be adjusted over a 
limited range and not as conveniently as in dynamic LPME. Dynamic LPME may 
also provide an attractive alternative approach to SPME. The two techniques are 
comparable in terms of precision, sensitivity, analysis time, and facility of automation. 
Dynamic LPME has the advantage that it can be easily performed in a microsyringe 
without any modification; and the sensitivity can be quickly adjusted over a wide 
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range by varying the number of samplings and the sampling volume. The problem of 
peak tailing often encountered in SPME can be reduced or eliminated. In addition, as 
with SPME several solid-phase coatings are available, a wide variety of organic 
solvents can be used in LPME for different target compounds. Preliminary studies 
have shown that even organic solvents heavier than water (e.g., chloroform) can be 
used in dynamic and probably static LPME.   
 
Figure 1-2 Expanded views of dynamic LPME within the microsyringe. 
 
3.2.1.3 Liquid-phase microextraction /back extraction 
In LLE, organic compounds in a broad polarity range may be co-extracted owing 
to the relatively non-selective nature of organic solvents, and consequently may 
interfere in the analysis. To overcome this shortcoming, Ma and Cantwell developed a 
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technique by combining microextraction into a solvent film with back extraction into 
a microdrop [34].The final receiving phase was a 0.5-1 µl aqueous microdrop (pH 2), 
suspended in a 30-µl n-octane liquid membrane confined in a Teflon ring. The 
n-octane membrane was exposed to an aqueous sample at pH 13. The use of a fresh 
organic membrane for each extraction in solvent microextraction /back extraction 
(SME/BE) eliminates memory effects and long-term instability problem. No solvent 
evaporation or desorption was required and the aqueous receiving phase (microdrop) 
was introduced directly to HPLC. Solute adsorption at the n-octane aqueous interface 
reduced mass transfer rate. Convection in the organic membrane phase, caused 
indirectly by magnetic stirring of the sample, was shown to accelerate the extraction 
rate.  Later the technique was extended in the form of a single microdrop suspended 
in the organic membrane phase from the tip of a microsyringe needle to enlarge the 
phase ratio between the acceptor phase and donor phase. In this way, extremely high 
enrichment factors were obtained in a relatively short time [88].   
3.2.1.4 Head-space LPME 
Shen and Lee developed headspace liquid-phase microextraction (HS-LPME) 
from dynamic LPME and applied it to extract volatile compounds from soil [89]. In 
HS-LPME, the syringe tip was held in the headspace of the vial and the sample 
withdrawn into the syringe was gaseous. The organic solvent film (OSF) formed in a 
microsyringe barrel through the movement of the plunger was used as the extraction 
interface. There was a wide selection of organic solvents. Some with high vapor 
pressures such as hexane and cyclohexane can be used as extractants since they were 
afforded greater protection within the syringe barrel and suffered no significant loss 
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during the procedure. The reasons for successful extraction are the very small space 
(5mm3) within the microsyringe barrel and the fast equilibrium between gaseous 
analytes and organic solvent film. Both of these factors significantly reduced the risk 
of solvent loss during extraction. The effects of sampling volume, organic solvent 
volume, syringe withdrawal rate, and number of extraction cycles were investigated.  
HS-LPME provides an alternative method for analysis of volatile compounds in 
“dirty” matrixes. Because only 2 µL of organic solvent and 25 extraction cycles (~4.2 
min) were adopted, the method was inexpensive and fast. Moreover, it has the 
potential of being automated, ensured better precision and sensitivity than manually 
operated system. There are some disadvantages. First, the procedure is generally 
more applicable to compounds with high Henry’s law constants. Second, in 
comparison to SPME, HS-LPME gives poorer although still acceptable detection 
limits compared with EPA method 8270 (however, this can be balanced by 
significantly shorter extraction time). With automation, more extraction cycles would 
address this drawback. 
SDE provides a fast, accurate and relatively inexpensive extraction sample 
preparation technique. Compared to conventional LLE and SPE, SDE gives much 
better enrichment efficiency. The consumption of solvent as well as the overall 
sample preparation time is significantly reduced. The configuration and operation of 
the SDE device is very simple. SDE integrates sampling, extraction, concentration, 
and sample introduction into a single step and offers a solvent-free alternative to the 
traditional methods. In addition SDE is easy to automate with the commercial 
autosamplers. However, some practical considerations limit its applications. The 
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major problem of SDE is that the microdrop suspended on the needle of microsyringe 
is easily dislodged by the stirred aqueous sample. Selection of a syringe with a 
beveled needle tip [85], suitable solvent [90], and a very small volume of solvent (~1 
µl) can obviate but cannot solve the problem completely, thus limiting the 
development and application of SDE. Furthermore, SDE works best with clean 
matrices, because particles or bubbles in the sample affect the extraction by making 
the drop unstable, and (for particles) are potentially detrimental to the analytical 
instrument. The drop stability limited the exposure time and stirring speed, thus 
compromising the extraction performance since higher stirring speeds and longer 
extraction time could enhance the extraction yield. There is certainly room to improve 
on the microdrop stability.  
 
3.2.2 Hollow fiber-protected microextraction 
Hollow fiber-protected LPME (35, 92-102) has been developed to address the 
disadvantages of SDE. A porous hollow fiber membrane was used to protect the 
solvent drop during extraction, in which the configuration of the extraction solvent 
was rod-like rather than spherical, that increases the solvent surface area since for the 
same volume the surface area of a sphere is the smallest. The contact area between 
sample solution and extracting solution is also increased, thus leads to better 
extraction efficiency. Another significant advantage is that higher stirring speeds can 
be applied during the extraction procedure, since the solvent is protected by the 
hollow fiber and its stability is enhanced. The concept was similar to LPME 
technique utilizing the back-extraction principle, but with hollow fiber protection, the 
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extractions were performed with very simple and disposable equipment. The porous 
polypropylene hollow fiber with impregnated organic solvent was used as an interface 
between acceptor phase and donor phase. The fiber provided reasonable selectivity. 
The high ratio between the sample volume and the acceptor phase volume provided 
an excellent basis for high analyte enrichments. This ratio in combination with the 
back-extraction concept ensured very efficient sample clean-up even from complex 
biological samples. 
3.2.2.1 Liquid-liquid-liquid microextraction 
In earlier work reported by Palmarsdottir and coworkers, a supported liquid 
membrane (SLM) was applied for the analysis of basic drug bambuterol and 
physostigmine in human plasma [92-94]. With this technique, basic drugs were 
extracted from a stream of plasma sample (donor solution) into an organic solvent 
immobilized in a porous poly(tetrafluoroethene) membrane or hollow fiber and 
subsequently back-extracted into a stagnant aqueous acceptor phase on the other side 
of the membrane . Because the acceptor solution was acidic and the donor solution 
was alkaline, and since the volume of the donor phase was larger than that of acceptor 
phase, the basic drugs were enriched within the acceptor solution. However, the 
experimental setup for this promising technique was relatively complex and required 
a peristaltic pump, a syringe pump and a special SLM unit machined from blocks of 
PTFE.  
Pedersen-Bjergaard and Rasmussen demonstrated a novel method 
liquid-liquid-liquid microextraction (LLLME) for concentration of methamphetamine 
from samples prior to CE analysis [35]. LLLME has been developed based on the 
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basic principle of SLM by utilizing polypropylene hollow fiber as the membrane. 
Polypropylene hollow fiber membrane (8cm length, I.D. 600 µm, wall thickness 200 
µm, 0.2 µm pore size) was first dipped into the organic solvent (1-octanol), which 
filled the pores on the wall of the hollow fiber. An aqueous acidic acceptor solution 
(25 µl) was introduced inside the hollow fiber. The hollow fiber was then exposed to 
sample (2.5ml, pH13). Due to the pH difference between the donor and acceptor 
phases, the analytes were extracted from the sample into the organic solvent 
immobilized in the pores of the hollow fibers, and further into the aqueous acceptor 
solution inside the hollow fiber. For analyte i, the extraction equations can be written 
as  
                        K1  K2 
ia1↔io↔ia2                  
where a1 represents the aqueous donor phase, o represents the organic phase within 
the pores of the hollow fiber, and a2 represents the aqueous acceptor phase. K1 and K2 
are the distribution ratios defined by  
                       K1= Co,eq/Ca1,eq                   (1-5) 
and                   K2= Co,eq/Ca2,eq                   (1-6) 
Ca1,eq, Co,eq, Ca2,eq are the equilibrium concentrations of i in the donor phase, organic 
phase and acceptor phase respectively. At equilibrium, the mass balance in the 

















CK ++                (1-7)           
where Ca1,initial is the initial concentration of i in the donor phase, Va1, Vo, Va2 are the 
volumes of the donor phase, organic phase and acceptor phase respectively. 
The enrichment factor (EF), defined as EF = Ca2,eq/C a1,initial, can be calculated as  
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K ++ )                  (1-8) 
Since Vo is very small, equation can be simplified as  








+ )                         (1-9) 
where       K= Ca2,eq / C a1,eq                           (1-10) 
It is obvious from equation that large K and phase ratio Va1/Va2 will result in a higher 







V C a1,initial                        (1-11) 
This condition represents complete extraction (i.e., 100% recovery) of analyte from 
the sample to the aqueous receiving phase at equilibrium.  
After extraction, the acceptor solution was transferred to a 200 µl vial by air 
pressure. The diagram of the LLLME extraction device is shown in Figure 1-3. This 
method was successfully applied to the analysis of urine and plasma [95, 96]. 
Rasmussen et al. extended the above work for application to GC and HPLC in 
addition to CE analysis [97]. For HPLC and CE, the method used was as described 
above. For GC, the hollow fibre was filled with organic solvent. Between 10 and 30 
samples could be extracted in parallel. The hollow fibre selected (polypropylene) is 
compatible with both aqueous solutions and a broad range of organic solvents. 
Pedersen-Bjergaard and Rasmussen applied the technique to analysis of the acidic 
drugs ibuprofen, naproxen and ketoprofen [98]. In this case the donor solution was 
acidified with HCl, and the aqueous acceptor solution was NaOH. Near 100% 
extraction efficiency was observed. The hollow fibre was sonicated following 
impregnation. Several other peaks appeared, as urine is known to contain several 
  24
acidic compounds. The fiber provided reasonable selectivity so that LLLME could be 
effectively used in the extraction of drugs from plasma.  
 
Figure 1-3 Schematic of liquid-liquid-liquid microextraction. 
 
Zhu and Lee simplified the LLLME device to a hollow fiber affixed to the needle 
of a commonly used microsyringe [99]. In this assembly, as shown in Figure 1-4, the 
microsyringe functioned as a microseparatory funnel for extraction as well as a 
syringe for injection into the HPLC. This method is compatible with both HPLC and 
capillary electrophoresis. The method was applied to analyze drugs in different matrix 
[100].  
The versatility of LLLME cannot be overstated. In conventional SPME or LPME, 
the analytical technique to analyse the extracts is GC, with LLLME, RP-HPLC and 
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CE (aqueous based techniques) can now be used. 
 
Figure 1-4 Schematic of the LLLME extraction device. 
 
3.2.2.2 Static LPME with hollow fiber and dynamic LPME with hollow fiber 
Static LPME and dynamic LPME combined with hollow fiber (HF) were 
reported by Shen, Zhao and Lee [101, 102]. In both static LPME with HF and 
dynamic LPME with HF, a small volume of organic solvent is impregnated in the 
hollow fiber, which is held by the needle of a conventional GC syringe. In static 
LPME/HF, the hollow fiber impregnated with solvent is immersed in the aqueous 
sample, and the extraction is processed under stirring; in dynamic LPME/HF, the 
solvent was repeatedly withdrawn into and discharged from the hollow fiber by a 
programmatic syringe pump. The reproducibility of this semi-automated LPME/HF 
was focused to much better than that of manually operated dynamic LPME procedure. 
The disadvantage of dynamic LPME/HF is that the operational speed was limited by 
capabilities of the syringe pump used in the work; thus, the number of samplings was 
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reduced over a particular extraction time period. A syringe pump that allows faster 
syringe manipulation would have been desired, according to the authors [102]. 
 
4 Objectives of this work 
 
 
The main objective of the present study is to develop the methodology of 
liquid-liquid-liquid microextraction (LLLME), and to examine the factors that 
influence it, and to evaluate the applicability of the method to drug analysis. 
For this purpose, the present research work mainly focused on the investigation of 
LLLME in combination with different analytical technique (CE, LC-MS and 
RP-HPLC) in the analysis of drugs. A novel extraction method, two-step LLLME was 
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Capillary electrophoresis (CE) has emerged as an effective analytical tool for the 
determination of a number of clinically relevant analytes [103, 104]. It provides high 
separation efficiencies, rapid separations and minimal reagent consumption. CE has 
been applied to the analysis of pharmaceuticals [17, 105, 106], identification of illicit 
drug substances [107, 108], detection and quantitation of intoxicants and the 
monitoring of a number of different classes of drugs [109]. However, the applicability 
of CE suffers from its relatively high concentration detection limits. To obviate this 
shortcoming, sample preconcentration is necessary. In addition, sample cleanup is 
required for complicated biological and environmental samples prior to the analysis 
by CE.  
Amino alcohols (β-blockers) are a class of drugs that can be determined by CE 
[110]. They are used for the treatment of various cardiovascular disorders such as 
hypertension, angina pectoris, and cardioarrhythmia [111-113]. Usually amino 
alcohols are present at low concentrations in aqueous matrices. Therefore, sample 
preparation must be carried out before the drugs can be determined. 
Recently, sample workup of drugs has been reported with liquid-phase 
microextraction (LPME) for CE utilizing polypropylene hollow fibers [35, 95, 98]. 
This technique is simple and inexpensive with the added benefit of the fiber being 
disposable after use. The deionised analytes (the analytes were contained in a basic 
donor solution) were extracted from the sample solution into the organic solvent 
impregnated in the pores of the hollow fiber, and further into the inside of the hollow 
fiber holding a small volume of an aqueous acidic solution providing high solubility 
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for the analytes (acceptor phase). Due to the acidic nature of the acceptor phase, the 
analytes were ionized, and were prevented from re-entering the organic solvent. The 
LLLME system provided simultaneous extraction and back-extraction. It also served 
as a method for sample clean-up and provided very clean extracts. The method has 
three advantages: (1) it can be used for a large number of different samples providing 
a high sample capacity due to the low cost of each extraction unit (the hollow fiber); 
(2) sample carry-over is avoided due to the extraction unit being disposable and the 
use of fresh sample and fiber for each extraction; (3) high partition coefficients of the 
analytes and high volume ratio between the sample and the acceptor solution (sample, 
3.5 mL; acceptor phase, 5µL) make possible high enrichment factors in the extraction.  
Different aspects of the extraction procedure such as the kinds of organic solvent 
suitable for the immobilization, composition of the acceptor and donor phase and the 
extraction time were investigated.  
 
2 Materials and methods 
 
2.1 Apparatus 
Separation was carried out on a Prince (Prince Technologies, Emmen, The 
Netherlands) CE system equipped with a UV detector, with detection at 195 nm. A 
60-cm (effective length 47 cm) × 50 um I.D. bare fused-silica capillary tube was used 
for CE. The support buffer was 30 mM Tris-H3PO4 adjusted to pH 2.5 with 
concentrated phosphoric acid. The voltage during separations was 20 kV. Samples 
were injected by pressure (100 mbar). 
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2.2 Materials 
Hydrochloric acid (HCl) (37%) and sodium hydroxide (NaOH) of analytical 
grades were obtained from Merck (Darmstadt, Germany). Phosphoric acid was 
purchased from Carlo Erba (Milan, Italy). Tris(hydroxymethyl)aminomethane (Tris) 
was purchased from J.T. Baker (Phillipsburg, NJ, USA). 1-Octanol (>99.5%), 
isooctane, n-hexane and di-n-hexyl ether were obtained from Merck. All of the 
reagents used were of analytical grades. Ultrapure water with extremely low TOC 
levels of between < 4 ppb to < 1 ppb was produced on a Nanopure system (Barnstead, 
Dubuque, IA, USA). Atenolol was purchased from Sigma (St. Louis, MO, USA). 
Norephedrine, pindolol and 2-amino-1-phenylethanol were purchased from Aldrich 
(Milwaukee, WI, USA). Their structures are shown in Figure 2-1. Amino alcohols 
were dissolved in methanol to make stock solutions at concentrations of 1 mg/ml. 
Mixtures containing each amino alcohol at different concentrations in 1 M NaOH 
were parepared from the stock solutions and used as working solutions. All solutions 





























Figure 2-1 Chemical structures of amino alcohols. 
2.3 Extraction of water samples 
The LLLME extraction device is illustrated in Figure 2-2. The sample solution 
was filled into a 4-ml vial. One conventional 10-µl HPLC syringe (Hamilton, 
Australia) of 0.8 mm O.D. was used to introduce the acceptor solution into the hollow 
fiber prior to extraction and support the hollow fiber. It was also utilized for 
collection and injection of the acceptor solution after extraction. Because the 
extraction units should be compatible with both aqueous solutions and organic 
solvents, Accurel Q3/2 polypropylene hollow fiber (Membrana, Wuppertal, Germany) 
was selected. The inner diameter of the hollow fiber was 600 µm, the thickness of the 
wall was 200 µm, and the pore size was 0.2 µm. A sample solution (prepared in 0.1 or 
1 M NaOH solution) of volume 3.5 ml was placed in a 4-ml sample vial. 5 µl of 
acceptor solution (either 0.1 M HCl or 0.05 M HCl, etc., as discussed below) was 
injected into a 2-cm length of hollow fiber (the other end of the hollow fiber was 
flame-sealed) with the 10-µl syringe. The hollow fiber, affixed on the needle, was 
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subsequently dipped for 5 s in the organic solvent (typically 1-octanol) used for 
impregnation; the latter procedure served to fill the pores of the hollow fiber with 
organic solvent. The hollow fiber was then placed in the sample solution. During the 
extraction, the sample solution was agitated at a stirring rate of 1000 rpm. After 
extraction, the acceptor solution was withdrawn back into the syringe and injected 
into a 200-ul vial. The solution (5 µl) was reconstituted with 35 µl aqueous solution 
containing 30 mM Tris-H3PO4, prior to CE analysis. Figure 2-3 shows a typical 
electropherogram of four amino alcohols after LLLME of a spiked water sample. 
 
Figure 2-2 Schematic of the LLLME device. 
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Figure 2-3. Electropherogram of a spiked water sample (2 µg/ml) obtained by 
LLLME-CE. Capillary: 60-cm (effective length, 47 cm) × 50-µm I. D.; buffer, 30 mM 
Tris-H3PO4 (pH 2.5); detection, UV 195 nm; voltage, 20 kV; injection, 100 mbar·s; 
injection time, 0.1 min. Peaks: (1) 2-amino-1-phenylethanol; (2) norephedrine; (3) 
pindolol; (4) atenolol. 
 
 
3 Results and discussion 
 
 
3.1 Selection of organic solvent for impregnation of the hollow fiber 
It was one of the critical steps in LLLME to select an organic solvent for 
pretreatment (immobilization) of the porous polypropylene hollow fiber. Based on 
earlier LLLME experience, 1-octanol and di-n-hexyl ether were evaluated as 
immobilization solvents. Both were easily immobilized on the polypropylene hollow 
fiber; furthermore, they were immiscible with water and their volatilities were low. 
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n-Hexane and isooctane were also investigated as immobilization solvents, but no 
enrichment of the analytes was observed. This may be related to the relative 
incompatibility of polarity between these solvents and the amino alcohols. With 0.1 
M HCl as the acceptor phase, 1 M NaOH in the 3.5 ml donor phase and 40 min 
extraction of all the amino alcohols, 1-octanol was found to provide higher 
preconcentration of the four compounds than di-n-hexyl ether (Table 2-1). This is 
probably due to the relatively higher polarity of 1-octanol and its greater affinity for 
the amino alcohols. On the basis of the above experiments, 1-octanol was selected as 
immobilization solvent for the rest of this study. 
Table 2-1. Efficiencies of different impregnation solvents.a 
Aminoalcohol Enrichment(-fold) 
 1-octanol di-n-hexylether 
2-Amino-1-phenylethanol 20 16 
Norephedrine 22 13 
Pindolol 29 15 
Atenolol 14 10 
n=3 
aWater samples at a concentration of 2 µg/ml of each compound. Data were 
obtained from mean values of three determinations. 
 
3.2 Composition of the acceptor phase and donor phase 
The composition (pH) of both the donor and acceptor solutions was another 
important parameter in LLLME. Basically, the acceptor phase should be strongly 
acidic in order to promote dissolution of the alkaline analytes while the donor phase 
should be strongly alkaline in order to deionize the analytes and consequently reduce 
their solubility within the sample. In this way, a high partition coefficient results 
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leading to high preconcentration by LLLME. In this study, we chose HCl at different 
concentrations as acceptor solution and NaOH at different concentrations as donor 
solution. Table 2-2 gives the results of optimizing the composition (based on pH) of 
both the donor and acceptor solutions. All the experiments were conducted over 40 
min with 1-octanol as the solvent for impregnation of the hollow fiber. From Table 
2-2, we see that the preconcentration factors were not significantly affected by the 
NaOH concentrations (donor phase) while the preconcentration factors were 
senstitive to the HCl concentrations (acceptor phase). On the basis of the above 
experiments, 0.1 M HCl and 1 M NaOH were selected as the acceptor solution and 
donor solution, respectively, for the rest of the work. 
 
Table 2-2. Enrichment of pindolol utilizing different donor and acceptor solutions. 
Donor, NaOH (M) Acceptor, HCl (M) Enrichment factor 
1 0.1 30 
1 0.05 10 
1 0.5 -a 
0.1 0.1 22 
0.1 0.05 7 
 
aProblems related to high ionic strength of sample (high concentration HCl matrix) 
during capillary electrophoresis (peak of pindolol could not be identified) 
 
3.3 Extraction time 
In this study, the preconcentration was studied as a function of extraction time 
(Figure 2-4). All the experiments were performed with the hollow fiber impregnated 
with 1-octanol, 1 M NaOH in the donor solution and 0.1 M HCl as the acceptor 
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solution. For all drugs, the preconcentration factors increased with extraction time up 
to 50 min. Since there was no significant change (increase or decrease) in 
preconcentration after 50 min of extraction, this time was selected. Although the 
extraction time was relatively long, simultaneous extracting a large number of 
































Figure 2-4 Plot of preconcentration factors for amino alcohols versus extraction time. 
Injection time, 1 min; other conditions as in Figure 2-2. 
 
3.4 Quantitative analysis 
Quantitative data are shown in Table 2-3. The extraction and determination of 
amino alcohols was performed with the optimum conditions, the LLLME acceptor 
phase was directly compatible with CE. Linearity was observed over the range of 
0.5-5 µg/ml for the analytes except for atenolol (1.0-10 µg/ml). Coefficients of 
correlation (r2) were all above 0.9940. Six replicate experiments of amino alcohols (1 
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µg/ml) were investigated under the optimized conditions to give 9.90-20.1% RSD 
without using the internal standard, while the results were improved to 6.3-8.9% RSD 
when correlations were applied based on 2-amino-1-phenylethanol (1 µg/ml) as 
internal standard. The repeatability was acceptable and comparable with other 
microextraction techniques reported in the literature. The limits of detection (S/N=3) 
range from 0.3 to 0.8 µg/ml. 
 
Table 2-3. Quantitative results of LLLME-CE.  
RSD(%)a Amino alcohols Enrichment 
(-fold) 
LOD 
(µg/ml) No corrections with IS Corrections with IS
2-Amino-1-phenylethanol 45 0.5 9.90 NCb 
Norephedrine 45 0.5 17.6 8.9 
Pindolol 50 0.3 20.1 IS 
Atenolol 35 0.8 18.3 6.3 
a n=6 
b Not considered since RSD increased after corrected with pindolol as IS. 
 
4 Summary 
The present work has demonstrated the potential of using LLLME for the 
extraction of amino alcohols from aqueous samples, followed by CE analysis. Based 
on disposable extraction devices, the extraction is simple, inexpensive and easy to use. 
The amounts of materials used (acceptor phase, 5 µl; donor phase, 40 µl, the 
minimum needed for one CE system) were relatively low. The LLLME method has 
been demonstrated to be precise, reproducible and linear over a wide range.  














Liquid-liquid-liquid Microextraction of Anesthetics in 
















Local anesthetics are drugs mainly used to reversibly block nerve function [114]. 
They are widely used for various local or regional treatments. These drugs cause 
occasional medical accidents. Because of this, the search for methods that allow simple, 
rapid, sensitive, selective and reproducible determination of local anesthetics from human 
body fluids is of great interest [115, 116]. 
Liquid chromatography-mass spectrometry (LC-MS) is a powerful tool for 
identification and quantitation in the pharmaceutical and bioanalytical fields [117-125]. 
Before LC-MS analysis, sample preparation is mandatory to prevent the clogging of the 
analytical column and to reduce MS signal suppression due to the presence of coeluting 
matrix compounds. The matrix effect may reduce the ionization efficiency of the analytes 
and cause poor reproducibility and accuracy. Eliminating matrix effect is especially 
dependent on the degree of sample purification. Commonly used preparation methods are 
liquid phase extraction (LLE) and solid-phase extraction (SPE) [95, 97, 98, 126, 127]. 
However, LLE and SPE use large amounts of high-purity organic solvents, and are time- 
and labor-intensive. As the low volume ratios between the samples and the final extracts, 
the analytes are typically preconcentrated by a factor of less than 10-20 prior to the final 
chromatographic analysis. 
In this work, a new sample preparation technique, liquid-liquid-liquid microextraction 
(LLLME) is developed to extract anesthetics from urine prior to LC-MS analysis. This 
technique uses disposable polypropylene hollow fibers as extraction device. It offers high 
preconcentration and efficient sample clean up. In LLLME, analytes are extracted from 
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small volumes of biological samples through an organic solvent in the pores of a porous 
hollow fiber and into a microliter volume of acceptor phase inside the hollow fiber. High 
enrichment is a result of the large volume difference between the sample solution and the 
acceptor solution. As the price of polypropylene hollow fibers is low, each LLLME 
extraction unit is cheap, compared with LLE or SPE. Each hollow fiber is used only for a 
single extraction so to avoid carry-over effect between extractions. Matrix effect can be 
reduced to a minimum. LLLME can contribute to the simplification of the sample 
preparation step. Since small volumes of organic solvent are used, thus obviating the 
need for solvent evaporation and reconstitution of the extract. 
   The LLLME-LC-MS method was validated and utilized for analysis of the 
anesthetics in human urine. It is demonstrated that LLLME-LC-MS is a promising 
approach for trace analysis in biological fluids. It is believed that this is the first report of 





2.1 Liquid-liquid-liquid microextraction  
The LLLME apparatus is shown diagrammically in Figure 2-1. The sample solution 
was placed in a 4-mL sample vial. The sample vial was clamped above the magnetic 
stirrer (Heidolph, Kelheim, Germany). A conventional 10-µl HPLC syringe of 0.460 mm 
I.D. was used to introduce the acceptor phase into the hollow fiber prior to extraction, 
support the hollow fiber and also to serve as a sample collection device after extraction. 
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Before every extraction, the syringe was rinsed 10-15 times with pure water and 
methanol to avoid the carryover of analytes between extractions.  Accurel Q3/2 
polypropylene hollow fiber was used owing to its excellent compatibility with a broad 
range of organic solvents. (Polypropylene is not soluble in any solvent at room 
temperature, making them solvent-resistance until brought to a higher temperature where 
nonpolar solvents can swell or dissolve the coating.) No degradation of the hollow fiber 
was observed following impregnation (incorporation of solvent into the porous wall) as 
the hollow fibers could be reused and they keep the same efficiency. The hollow fiber 
was cut to produce 2.2-cm segments with one end flame-sealed and then sonicated for 2 
min in HPLC-grade acetone to remove any contaminants in the fiber. After sonication, 
the fibers were removed from the acetone, and the solvent was allowed to evaporate 
completely. These hollow fiber segments were used for subsequent extractions. Magnetic 
stirring bars were placed into the solutions to provide efficient stirring during the 
extractions.  
   Extractions were performed according to the following scheme:  a 4-mL sample 
solution was placed in the sample vial. A 12 mm × 4 mm magnetic stirring bar was 
placed in the solution. Subsequently, 5-µL of acceptor solution (HCl, at the concentration 
described below) was withdrawn in the 10-µL HPLC syringe. For LLLME parameter 
optimizations, the solvent was injected directly into the HPLC for analysis. For analysis 
by LC-MS in the method evaluation exercise, the solvent was first injected into a 200-µl 
vial, reconstituted with 15µl methanol and subjected to vibration for 30 s to obtain a 
homogeneous solution prior to LC-MS analysis. Each piece of hollow fiber was used 
only for a single extraction. 
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2.2 Instrumental analysis 
2.2.1 High-performance liquid chromatography (HPLC) 
 
  The HPLC system comprised of a Shimadzu (Kyoto, Japan) LC-6A pump, a 
Rheodyne (Cotati, CA, USA) 7125 injector equipped with 10-µL sample loop, a 
Shimadzu SPD-6A variable-wavelength UV-Vis spectrophotometric detector and a 
Shimadzu C-R6A integrator for data collection and analysis.  
  Chromatography was performed on a Genesis C18 column (150×3 mm I.D., 4µm 
particle size) (Jones Chromatography, MG, UK) using HPLC-acetonitrile -ammonium 
acetate (70: 30, v/v) (1M, pH 5) as the mobile phase at a flow-rate of 0.4 ml/min under 
ambient temperature (22oC). The UV detection wavelength was 254 nm. The injection 
volume was 2 µL. 
2.2.2 LC-MS 
 
2.2.2.1 HPLC  
 
The HPLC instrument was equipped with vacuum degasser (model SCM1000) (San 
Jose, CA, USA), narrow-bore Quat gradient pump (model P4000), narrow-bore 
variable-loop autosampler (model AS3000), and UV detector (model 6000LP) (all 
Finnigan MAT). The system was coupled on-line to a mass selective HP MS detector 
(Finnigan MAT). The system was controlled by the Xcalibur software. 
In the gradient system, solvent A was acetonitrile whereas solvent B was 30% 20mM 
ammonium acetate (pH5) and 70% acetonitrile. The solvents were degassed by an in-line 
vacuum degasser. The elution mode was a linear gradient from 100% B in 15 min to 30% 
B in 30 min at a flow rate of 0.4 mL/min. After the compounds were separated, the 
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mobile phase was changed to 100% B within 2 min for equilibration of the column, 
achieving a total run time of 32 min/sample. Typically, a volume of 5µL was injected and 
the HPLC effluent was directed to the MS. 
 
2.2.2.2 Electrospray ionization mass spectrometry  
Mass spectrometry was performed on an LCQ ion trap instrument (Finnigan MAT) 
equipped with an electrospray ionization source that was run in the positive ion mode. 
Sheath gas (N2) flow rate was set at 80 arbitrary units, and auxiliary gas flow rate was at 
20 arbitrary units. Ion spray voltage was set at 4.50 kV. The temperature of the heated 
capillary was kept at 250oC and the voltage of the capillary was 15 V. The tube lens offset 
was 15 V. Quantification of the anesthetics was carried out in the selective ion monitoring 
(SIM)-MS mode. The relative collision energy was set up at 35% for each compound. 
The MS system was controlled by the Xcalibur software.  
Mass spectra were recorded from m/z 50 to 250 and the data for the SIM mode were 
acquired at m/z 86 for lidocaine, m/z 140 for bupivacaine and m/z 271 for dibucaine.  
 
2.3 Reagents and standards 
 
Acetonitrile (HPLC grade), HCl (analytical grade) were supplied by J.T .Baker, 
NaOH, acetic acid, n-hexyl ether and 1-octanol were bought from Merck, n-octane 
(>99%) was purchased from Fluka (Buchs, Switzerland), and n-nonane from Fisher (NJ, 
USA). Ethyl acetate was purchased from Mallinckrodt (Paris, KY, USA).  All these 
reagents are of analytical grades. Ammonium acetate was bought from Ajax (Sydney, 
Australia). Methanol (HPLC grade) was purchased from Mallinckrodt. Ultrapure water 
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with extremely low TOC levels of between < 4 ppb to < 1 ppb was produced on a 
Nanopure system. Lidocaine, bupivacaine and dibucaine were purchased from Sigma. 
Their structures are shown in Figure 3-1. They were dissolved separately in methanol at 1 
mg/ml concentrations as stock solutions. Working solutions containing these three 
chemicals at different concentrations in 0.1M NaOH were prepared from the stock 








































Figure 3-1 Structures of Lidocaine, Bupivacaine and Dibucaine. 
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3 Results and discussion 
 
3.1 The effect of organic solvent 
Selection of the organic solvent to be immobilized (impregnated) in the pores of the 
hollow fiber is one of the most critical steps in LLLME in order to achieve efficient 
analyte preconcentration. The solvent should have low solubility in water to avoid 
dissolution and high boiling point to reduce evaporation. The partitioning coefficient of 
the analyte in the immobilized solvent should be higher than it is in the donor phase in 
order to promote analyte extraction. Ethyl acetate, n-octane, n-nonane, 1-octanol, n-hexyl 
ether were evaluated as possible solvents. When ethyl acetate and n-nonane were used, no 
compounds could be extracted; this may be because of the incompatibility of the solvent 
and the analytes. Subsequently, 1-octanol, n-octane and di-n-hexyl ether were compared. 
From Table 3-1, it is obvious that di-n-hexyl ether was the best extraction solvent among 
these three for the anesthetics analyzed. Thus, di-n-hexyl ether was selected as the 
organic solvent in this study. 
Table 3-1. Selection of organic solvents. 
 
Compound Enrichment factor (-fold) 
 1-octanol n-octane di-n-hexyl ether 
Lidocaine 71.75 68.34 91.37
Bupivacaine 68.76 210.34 252.3
Dibucaine 56.37 215.34 338.26
Extraction conditions: Organic solvent: n-hexyl ether. 0.1 M NaOH in the donor phase, 
0.1 M HCl as the acceptor phase. Stirring speed: 1000rpm. Extraction time: 20 min. 
Target compounds concentration: 50ppb. Data were obtained from mean values of three 
determinations. 
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3.2 Selection of acceptor phase 
The acceptor phase is another parameter of great importance in LPME. Basically, the 
acceptor phase should promote dissolution of the analytes so to enhance extraction. For 
all the experiments, LPME was accomplished for 20 min with 0.1 M NaOH in the donor 
phase. HCl with various concentrations was investigated as the acceptor phase. As 
illustrated in Table 3-2, the extraction efficiency was influenced significantly by the HCl 
concentration. It reached its highest value at 0.1 M HCl. Therefore, 0.1 M HCl was 
utilized for subsequent experiments. 
Table 3-2. The influence of acceptor phase on anesthetics preconcentration. 
 
Compound Enrichment Factor (-fold) 
 1M HCl 0.1M HCl 0.05M HCl 0.01M HCl 
Lidocaine 25.74 91.37 86.23 36.36 
Bupivacaine 229.2 252.3 246 248.76 
Dibucaine 169.41 338.26 313.37 310.83 
 
Extractions were conducted with 50 ppb target compounds, 0.1 M NaOH in the donor 
phase, di-n-hexyl ether as the organic solvent, on 20 min at 1000 rpm stirring speed. 
 
3.3 Selection of donor solution 
      The donor phase composition was also investigated in the experiment. With 0.1 M 
HCl in the acceptor phase, LLLME was carried out for 20 min. NaOH concentrations of 
1 M, 0.1 M and 0.01 M were tested. As shown in Table 3-3, the concentration of the 
donor phase has little influence to the extraction efficiency. Finally 0.1 M NaOH was 






Table 3-3. The influence of donor phase on anesthetic preconcentration. 
 
Compound Enrichment factor (-fold) 
 1M NaOH 0.1M NaOH 0.01M NaOH
Lidocaine 123.44 91.37 79.81
Bupivacaine 220.47 252.3 249.76
Dibucaine 221.54 338.26 347.45
 
Extractions were conducted with 50 ppb target compounds in the donor phase, 0.1 M HCl 
as the acceptor phase, di-n-hexyl ether as the organic solvent, on 20 min at 1000 rpm 
stirring speed. 
 
3.4 Effect of extraction time 
The enrichment was studied as a function of extraction time (Figure 3-3). All the 
experiments were performed with the hollow fiber impregnated with di-n-hexyl ether, 0.1 
M NaOH in the donor solution and 0.1 M HCl as the acceptor solution. For all target 
analytes, the amount extracted increased dramatically with increasing exposure time from 
1 to 70 min. After 70 min, there was a significant decrease in preconcentration. This may 
be the result of the loss of the organic solvent on the hollow fiber. On the basis of these 
results, 70 min was selected as the extraction time for the experiment. Although the 
extraction time was relatively long, simultaneous extraction of a large number of different 





























Figure 3-2 Effect of extraction time on enrichment factor. 
 
 
3.5 Effect of stirring speed 
Stirring the aqueous solution enhances extraction efficiency and reduces extraction 
time.  Fast agitation of the sample solution permits the continuous exposure of the 
extraction surface to fresh aqueous sample so to enhance the partitioning of the analytes 
into the organic phase [123]. As seen from Figure 3-3, the amount extracted reached its 
highest value at 1000 rpm and decreased beyond that. This is because since a small 
volume of solution was agitated at high speed, it was observed that excessive air bubbles 
were generated that adhered to the hollow fiber surface so to influence extraction 
negatively. It is also possible at high agitation speed, solvent loss occurred. Based on 

































3.6 Extraction efficiency 
On the basis of the experiments discussed above, optimal LLLME condition for the 
anesthetics were: di-n-hexyl ether as the impregnating solvent, 0.1 M HCl as the acceptor 
solution, 0.1 M NaOH in the donor solution, and an extraction time of 70 min at stirring 
speed of 1000rpm. In this case, Lidocaine was typically enriched by a factor of 324 from 
aqueous samples, 584 for Bupivacaine, 626 for Dibucaine.  
3.7 Method evaluation 
All the above optimizations of LLLME method were performed using HPLC. To 
evaluate the practical applicability of the proposed LLLME technique, repeatability, 
linearity, and detection limit were investigated by utilizing LC-MS with standard 
solutions of anesthetics in water. Quantification was carried out in the SIM-MS mode by 
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calculation the peak areas of the various analytes. As shown in Table 3-4, the results are 
generally satisfactory and acceptable. 
Table 3-4. Performance of LLLME-LC-MS. 
 
 
LLLME optimal conditions: 0.1 M NaOH in the donor phase, 0.1M HCl as the acceptor 




3.8 Spiked sample analysis 
   The applicability of this method for human urine samples was evaluated using the 
optimum conditions. Fig. 5 shows the MS spectrum of both the blank urine sample and 
spiked urine sample, which were investigated under the same conditions. From the results 
in Table 5, the analysis of spiked urine also gave good limit of detections.  
 
 













    Experiment conditions are as given in Table 3-4. 
 







lidocaine 8.5 50-500 0.9949 40 
bupicacaine 9.4 20-200 0.9983 10 
dibucaine 10.2 2-20 0.9993 2 
Compound RSD (%)  
(n=6) 
LOD (ng/mL)
Lidocaine 8.3 40 
Bupivacaine 9.5 2 




 Figure 3-4 LC-MS-SIM chromatogram of urine sample after LLLME (a) blank urine sample; (b) 




    
  In the present work LLLME was combined with LC-MS for the determination of 
drugs in biological matrices for the first time. The drugs investigated were three local 
anesthetics, Lidocaine, Bupivacaine and Dibucaine. LLLME resulted in high enrichment 
and efficient sample clean-up. The results showed that LLLME-LC-MS is a promising 
approach for drugs analysis in biological matrices. Further improvements in sensitivity 































Two-Step Liquid-Liquid-Liquid Microextraction of 
Nonsteroidal Anti-Inflammatory Drugs in Wastewater 
 






















    With the growing use of pharmaceutical products, drug residues have become 
significant contaminants in environmental waters. Nonsteroidal anti-inflammatory drugs 
(NSAIDs) are well-known drugs that are frequently used for the treatment of fever and 
minor pain and are available without prescription. Besides their usual therapeutic use, 
chronic abuse and accidental intoxications have been described [130-132]. Due to their 
biological activity these drugs are of great concern if released into the environment [133]. 
     Many analyses of NSAIDs are based on gas chromatography-mass spectrometry 
(GC-MS) [134-136], which often requires derivatization. Recently, analytical techniques 
based on reversed-phase high-performance liquid chromatography (RP-HPLC) have 
become the procedures of choice for determining drugs in environmental analysis 
[137-142]. As detection limits at the low ng/L levels are required, a preconcentration step 
is always necessary prior to HPLC analysis.  
    Conventional liquid-liquid extraction (LLE) requires large amounts of toxic organic 
solvents and is tedious and time-consuming. Solid-phase extraction (SPE) is the usual 
way for sample pretreatment of drug residues [131, 133-135, 143, 144]. However, SPE is 
relatively expensive and the enrichment factors obtained are relatively low without 
solvent evaporation. Liquid-phase microextraction (LPME) offers an effective alternative 
to classical sample preparation techniques. One LPME approach is LLLME. This novel 
technique as already described in the earlier chapter, is simple, fast and inexpensive. It 
uses minimal amounts of solvent that enables extraction and concentration steps to be 
carried out simultaneously. In the present work, we combined two LLLME steps (the first 
  52
step making use of ten pieces of hollow fiber, and the second step a single piece) to 
enhance enrichment factors for the extraction of NSAIDs from water. The main factors 
influential to this novel extraction approach such as the compositions of the acceptor 
phase and donor phase, and extraction time were investigated. The optimized conditions 
were evaluated for quantitative purposes and applied to wastewater analysis in 




2.1 Two-step liquid-liquid-liquid microextraction 
The experimental set-up is illustrated in Figure 4-1. For the first step, the sample 
solution was held in a 100-mL reagent bottle (Schott, Duran, Germany). Ten pieces of 
Q3/2 Accurel polypropylene hollow fiber were used to contain the acceptor solution. 
The length of each hollow fiber used was 53.5cm (as supplied). A 250-µL GC syringe 
(Hamilton, Reno, NV, USA) of 2.3 mm I.D. was used to introduce 100µL acceptor 
solution into the hollow fiber. For the second step, a single fresh hollow fiber (1.4-cm 
length) was flame-sealed at one end and a 10-µL HPLC syringe with 0.460 mm I.D. 
was used as shown in Figure 4-1, to introduce acceptor solution into the hollow fiber. 
The syringe also served to support the hollow fiber and finally to inject the acceptor 
phase into the HPLC system. Magnetic stirring bars were placed into the solutions to 
provide efficient stirring during the extractions.  
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Figure 4-1 Schematic of two-step LLLME device: (a) first-step extraction unit and (b) 
second-step extraction unit. In (a), for clarity, only 2 pieces of hollow fiber are shown. 
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    The organic solvent immobilized in the pores of the hollow fiber is a critical factor 
in LLLME. It is of major importance to extraction efficiency. The organic solvent 
served to separate two aqueous solutions (donor phase and acceptor phase). It should be 
compatible with the fiber so as to fill in the pores on the wall of the fiber and to create a 
suitable medium for extraction. It should also be immiscible with water and stable 
enough over the extraction time. The solubility of the analytes in the organic phase 
should be higher than in the donor phase but lower than in the acceptor phase so that 
the analytes could be transferred from the donor phase to the acceptor phase with high 
extraction efficiency [98, 101]. The toxicity of the solvent should also be considered. 
Based on all above consideration and previous studies [35, 95, 96, 98, 99,101, 146-150], 
1-octanol was selected as the organic solvent in this study. 
Extractions were performed according to the following scheme: A 100-mL aliquot of 
sample solution (pH adjusted with HCl as described below) was placed in the reagent 
bottle. A 1.4cm length ×0.4cm width magnetic stirring bar was placed in the solution. 
Ten pieces of hollow fiber (53.5cm length) were immersed in the organic solvent 
1-octanol for 5 s for impregnating solvent into the porous walls. The 250-µL GC 
syringe was used to inject 100 µL of acceptor solution (NaOH, at the concentrations 
described below) into each of the hollow fibers. The fibers were then placed in the 
sample solution. Both ends of the fibers were held out of the sample solution. The 
bottle was then capped. During the extraction, the bottle was placed on the MR3001K 
magnetic stirrer (Heidolph, Kelheim, Germany) for stirring. The stirring speed was 700 
rpm. After extraction, the hollow fiber segments were retrieved, and acceptor solution 
from each fiber was flushed into a 4-mL sample vial with high purity (99.9995%) 
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nitrogen. A 100-µL acceptor solution was injected into each fiber again for washing and 
then flushed again into the same vial as above. In the vial, HCl was added to adjust the 
pH of the solution. This was now the donor solution for the second step of the 
extraction. A 12 mm length ×4 mm width magnetic bar was placed in the solution. 
Subsequently, 2-µL of acceptor solution (NaOH, at the concentration described below) 
was injected into the short fiber with the 10-µL HPLC syringe. The fiber (with the 
syringe still attached) was dipped for 5 s into 1-octanol for impregnation and then 
placed into the donor solution in the sample vial that was placed on the magnetic stirrer 
for stirring during the extraction as in the first step. After extraction, the fiber (with the 
attached syringe) was removed from the solution and the acceptor phase was withdrawn 
into the syringe and subsequently injected into the HPLC system. For both steps, each 
piece of hollow fiber was used only for a single extraction. 
2.2    Instrumentation and chromatography 
    The chromatographic system comprised of a Shimadzu (Kyoto, Japan) LC-6A 
pump, a Rheodyne (Cotati, CA, USA) 7125 injector equipped with 10-µL sample loop, a 
Shimadzu SPD-6A variable-wavelength UV-Vis spectrophotometric detector and a 
Shimadzu C-R6A integrator for data collection and analysis.  
    Chromatography was performed on an Inertsil 5 ODS-2 (Chrompack, the 
Netherlands) (25cm ×2mm I.D.; 5µm particle size) column using methanol-ammonium 
acetate (75: 25, v/v) (1M, pH 5) as the mobile phase at a flow-rate of 0.1 ml/min under 
ambient temperature (22oC). The UV detection wavelength was 280 nm. The injection 
volume was 2 µL. 
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2.3    Reagents 
    HCl was supplied by J.T .Baker (Philipsburg, PA, USA). NaOH, acetic acid and 
1-octanol were bought from Merck (Darmstadt, Germany). All these reagents are of 
analytical grades. Ammonium acetate was bought from Ajax (Sydney, Australia). 
HPLC-grade methanol was purchased from Mallinckrodt (Paris, KY, USA). Ultrapure 
water with extremely low TOC levels of between < 4 ppb to < 1 ppb was produced on a 
Nanopure system (Barnstead, Dubuque, IA, USA). Ibuprofen (IBP) was purchased from 
Sigma (St. Louis, MO, USA) and 2-(4-chlorophenoxy)-2-methyl-propionic acid (MPA) 
was purchased from Aldrich (Milwaukee, WI, USA). (Their structures are shown in 
Figure 4-2) Both were dissolved separately in methanol at 1 mg/ml concentrations as 
stock solutions. Working solutions containing these two chemicals at different 
concentrations in 0.01M NaOH were prepared from the stock solution. 
 
      
CH3
CH3CH3





                IBP                                      MPA 
 
Figure 4-2 Structures of IBP and MPA. 
 
 
3 Results and discussion 
 
3.1  Basic principle of extraction 
   The principle of each step in two-step LLLME is the same as the principle of single 
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step LLLME described previously [148-150]. Analytes were extracted from the aqueous 
sample solution (donor phase) into the organic phase inside the pores of the hollow fibers 
and further into the aqueous acceptor phase inside the hollow fibers. As the analytes of 
interest were acidic substance, the aqueous sample (donor phase) was made strongly 
acidic with HCl to ensure they were in their neutral forms. Thus, the analytes could easily 
partition into the organic phase. Inside the hollow fibers, the alkaline solution permitted a 
higher solubility of the analytes than the organic phase did. The analytes were ionized in 
the alkaline acceptor phase and were prevented from re-entering the organic phase. Due 
to the high partition coefficients of the analytes and the high volume ratio between the 
sample and the final acceptor solution, high enrichment factors were obtained after the 
extraction. 
    In two-step LLLME, the alkaline acceptor phase of the first step was acidified with 
strong acid to deionize the analytes again to be the donor phase of the second step. In the 
first step, a 100% extraction recovery was obtained through optimization (referring to a 
preliminary study [98]). Thus, the extraction of the analytes was quantitative. Calculation 
and validation of the whole procedure could be simplified by basing them on the second 
step. As the analytes were extracted through LLLME twice, enrichment factors were the 
product of individual factors of each step. Thus a high overall enrichment factor was 
achieved. 
3.2  Donor and acceptor solutions 
    The pH values of the donor and acceptor solutions are very important parameters for 
optimizing the LLLME. As the two steps of the extraction are based on the same 
principles, we were able to simplify the optimization experiments based on the second 
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step of the extraction (using the 4-ml vial and 1.4-cm hollow fiber, as described in a 
previous study [99]). All the experiments were carried out with HCl in the donor phase 
and NaOH in the acceptor phase. Their concentrations were varied from 0.01M to 0.5 M, 
respectively. The fibers were impregnated with 1-octanol. The extraction was 
accomplished at room temperature (22oC) for 30 min at 700 rpm. As shown in Table 1, 
the biggest enrichment factors (EF) for both analytes were achieved when 0.05M HCl 
and 0.01M NaOH were used. These were utilized as the donor phase and acceptor phase 
for the second step of the extraction of the NSAIDs. 
 
Table 4-1. Effect of compositions of donor and acceptor solutions on enrichment factor. 
 
  Enrichment factor (-fold) 
  0.01M NaOH 0.05M NaOH 0.1M NaOH 0.5M NaOH 
0.01M HCl MPA 182.9 172.8 174.0 224.4 
 IBP 203.9 50.5 216.3 128.0 
0.05M HCl MPA 321.5 197.4 133.3 242.0 
 IBP 292.6 61.0 234.5 126.6 
0.1M HCl MPA 142.4 127.9 191.5 240.0 
 IBP 121.2 42.6 222.5 129.9 
0.5M HCl MPA _ _ 202.7 215.3 
 IBP _ _ 230.5 146.9 
 
Extraction conditions: Concentration, 50µg/L for MPA, 300µg/L for IBP. Extraction 
time, 30 min. Extraction stirring speed, 700 rpm. Data were obtained from mean 
values of three determinations. 
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   In the first extraction step, recovery of 100% was required. From a previous study [99] 
and the above experiments, 0.1M HCl and 0.01M NaOH were chosen for the pH of the 
donor phase and acceptor phase. 




k  [C]donor                       (4-1) 
              [C]=m/v                                  (4-2)    
where k1 is the equilibrium distribution coefficient between the donor phase and the 
organic phase, k2 is the equilibrium distribution coefficient between the organic phase 
and the acceptor phase. [C]acceptor is the concentration of the analyte in the acceptor phase; 
[C]donor is the concentration of the analyte in the donor phase. m is the amount of the 
analyte in the solution and v is the volume of the sample (donor) solution. 




k mdonor/vdonor                      (4-3) 
If 100% recovery is needed, this means 
              m acceptor = m donor                            (4-4) 
So            v donor /v acceptor =k1/k2                         (4-5)   
 
  From this first step of the extraction, we obtained 100% recovery with vdonor /vacceptor 
ratio of 100. As in Table 4-2, for vdonor /vacceptor ratios of 200 and 400, 100% recovery 
could not be obtained. This is because the volume of the acceptor phase is too small and 
the target compounds cannot be transferred quantitatively into the acceptor phase. 
Consequently, the ratio between the volumes of the donor phase and the acceptor phase 




Table 4-2. Verification of recovery of the first step two-step LLLME. 
 
Recovery (%) 
Volume of acceptor 
phase (µL) 
vdonor / vacceptor 
MPA IBP 
100 100 102.9 101.2 
50 200 89.9 100.5 
25 400 45.9 59.9 
 
Extraction conditions:  Volume of donor phase, 10 mL. Concentration, 50µg/L for 
MPA, 300µg/L for IBP. Extraction time, 30 min. Extraction stirring speed, 700 rpm. 
Data were obtained from mean values of three determinations. 
 
3.3   Effect of extraction time 
   As LLLME is a process dependent on liquid-liquid equilibrium, the extraction time 
was investigated by the simplified experiment mentioned above and described previously 
[99]. The effect of stirring the sample solutions was not studied here since it has already 
been demonstrated that rapid stirring enhanced dramatically the mass transfer in LLLME 
and thus extraction efficiencies. But fast stirring generates air bubbles on the surface of 
the hollow fiber, which leads to poorer precision and possible experimental failure 
[99,101]. Thus 700 rpm was selected as the optimum stirring speed. 25mM HCl and 
0.1M NaOH were used respectively in the donor phase and acceptor phase. The fiber was 
impregnated with 1-octanol. The experiment was performed at room temperature (22oC). 
The result is shown in Figure 4-3. As illustrated, IBP and MPA yielded the highest 
extraction factor after ~40 min extraction and extraction time longer than 40 min did not 




























Figure 4-3 Effect of extraction time on enrichment factor. Concentration, 50µg/L for 
MPA, 300µg/L for IBP. Donor phase, 25mM HCl , acceptor phase, 0.1M NaOH. 




3.4     Quantitative analysis 
     
    The performance of the procedure was studied at optimal conditions. As shown in 
Table 4-3, the calibration curve for MPA ranging from 0.06 to 2 µg/L exhibited an r2 
factor of 0.9996 with a relative standard deviation (RSD, n=6) of 8.62; the calibration 
curve for IBP ranging from 0 to 40 µg/L exhibited an r2 factor of  0.9994 with an RSD 





















MPA 1.65×104 8.62 0.03-100 0.9999 15 88.5 
IBP 1.50×104 21.2 0.2-500 0.9997 100 73.1 
 
Two-step LLLME optimal conditions: 0.1M HCl within the donor phase, 0.01M NaOH as 
the acceptor phase in the first step and 0.05M HCl within the donor phase, 0.01M NaOH as 
the acceptor phase in the second step, extraction time 40 min, extraction stirring speed 700 
rpm. 
 
3.5     Real-world water sample  
 
The proposed analytical method has been applied for the analysis of domestic 
wastewater in Singapore. A chromatogram of the wastewater (sample taken on 23th. Feb. 
2002), where IBP at a level of 0.229µg/L was found, is illustrated in Figure 4-4(a). The 
repeatability of the proposed method when analyzing real samples was good with the 
corresponding RSD value 19.9% (n=3). As no MPA was found in the original water 
sample, 1 ng/mL of both analytes were spiked in the wastewater. The chromatogram is 
shown in Figure 4-4(b). The relative recoveries were 89.0% for MPA and 76.0% for IBP, 
respectively. The corresponding RSD for MPA was 8.30 (n=3). It should be noted that the 
recoveries obtained for samples of pure water and wastewater were similar. This 
demonstrates that two-step LLLME is not influenced by the sample matrix. 
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Figure 4-4 Chromatogram of wastewater sample after extraction: (a) blank wastewater 







    The results of this work demonstrate the successful development and application of 
LLLME of NSAIDs from water samples, using ten pieces of hollow fiber for the first step, 
and a single piece for the second step. With the obvious advantages of high enrichment 
factor (up to 1.50×104-fold), the two-step LLLME is capable of achieving  lower 
detection limits (100ng/L and lower for NSAIDs) compared with other extraction 
techniques like LLE, SPE (200ng/L), SPME (0.1-10µg/L) and single step LPME 
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(1µg/L)[96,151]. As the extraction principle is the same as single-step LLLME, the 
optimization of the entire process can be simplified based on just one step, the second 
step. The procedure is convenient to operate and highly cost-effective. Potential memory 
effects of the fibers can be overcome by using fresh hollow fibers each time. Two-step 
LLLME has been shown to be effective for the pretreatment of domestic wastewater 
containing NSAIDs.  
 
 




















































The research described in the foregoing chapters clearly illustrated that 
liquid-liquid-liquid microextraction (LLLME) can be efficiently applied to drug analysis 
and as alternative methods to conventional macroscale sample preparation techniques. 
Liquid-liquid-liquid microextraction (LLLME), a new development of solvent 
microextraction that is based on the principle of supported liquid membrane (SLM), 
integrates sampling, extraction, concentration, and sample introduction into a single step 
and offers a solvent-free alternative to traditional methods. The LLLME setup is very 
simple. Normally, the sample vial is placed on a magnetic stirrer, which provides the 
agitation to facilitate the extraction. The microdrop of aqueous solution (acceptor phase) 
was introduced into a small porous polypropylene hollow fiber by a microsyringe and 
held at the tip of the needle throughout the whole extraction. The fiber is then dipped for 
5 s into the organic phase for impregnation of the porous wall, and then placed into the 
donor solution in the sample vial. The syringe is fixed on the retort stand. The magnetic 
stirrer is switched on to start the extraction. After a prescribed time, the fiber (with the 
attached syringe) is removed from the sample solution. The extract in the fiber is 
withdrawn into the syringe and directly analyzed.  
In LLLME, the porous polypropylene hollow fiber with impregnated organic solvent 
is used as an interface between the acceptor phase and the donor phase. Because of the 
small size of the pores, particles and unwanted large molecules in the matrix are 
prevented from interfering with extraction so that LLLME can be effectively used in the 
extraction of drugs from biological matrix. With selective extraction, sample preparation 
is simplified and typically results in a significant savings in time and precision.  
LLLME was demonstrated to be an effective method for sample preparation in drug 
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analysis when combined with CE and LC/MS. The factors influencing extraction 
efficiency such as selection of organic solvent, composition of acceptor phase and donor 
phase, extraction time, and stirring speed were investigated and optimized. Good 
enrichment factors, linearity and precision were obtained.  
In a novel approach to LLLME, two-step LLLME was developed and shown to be 
more efficient than basic one-step LLLME. Two-step LLLME was demonstrated to 
provide high enrichment factors, thus allowing the achievement of low detection limits 
for the analysis of non-steroidal anti-inflammatory drugs in domestic wastewater. 
There is one limitation of the microextraction techniques developed in this work: the 
difficulty in automating the process especially in providing on-line integration with 
various instrumental techniques. Clearly this is a challenging problem that should be a 
focus of any future work on these techniques. Nevertheless, the procedures developed in 
this work have been shown to be very easy to use and give very good analytical data, and 
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